About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,019 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,019 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3001-3020 of 13,019 trials

CompletedVestibular Rehabilitation and Dizziness in Geriatric PatientsThe purpose of this study is to develop effective exercise intervention to reduce dizziness and fall risk in older adults with non-specific dizziness.NCT00275392·Decatur, Georgia TerminatedStudy of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of 2 fixed doses of EVP-6124 compared to placebo for 26 weeks in subjects with mild to moderate Alzheimer's…NCT01969136·Tucson, Arizona and 80 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

CompletedA Sleep Intervention (SLEEP-Extend) for Young Adults At-Risk for Type 2 DiabetesThe study is a prospective unblinded randomized trial to evaluate the feasibility of conducting a sleep extension intervention trial and the sleep extension intervention among the…NCT03616171·Atlanta, Georgia and 1 other

CompletedOpen Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUSThe purpose of this study is to determine whether eculizumab is safe and effective in the treatment of adolescent patients with plasma therapy-resistant Atypical Hemolytic-Uremic…NCT00844844·Atlanta, Georgia and 16 others

CompletedA Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active ComparatorThis is a 24 week study comparing the efficacy of four dose levels of INT131 besylate with pioglitazone HCl in patients with type 2 diabetes.NCT00631007·Carmichael, California and 65 others

CompletedThe Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionThe Safety and Efficacy of Psilocybin in Participants with Treatment Resistant DepressionNCT03775200·La Jolla, California and 24 others

CompletedPembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)This is a study of pembrolizumab plus gemcitabine/cisplatin versus placebo plus gemcitabine/cisplatin as first-line therapy in participants with advanced and/or unresectable…NCT04003636·Birmingham, Alabama and 184 others

TerminatedStudy to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaThe primary objective of this study is to evaluate the safety and tolerability of brexucabtagene autoleucel (KTE-X19) in adults with relapsed/refractory chronic lymphocytic…NCT03624036·Phoenix, Arizona and 21 others

CompletedB-type Natriuretic Peptide in the Non-Cardiac Pediatric PatientB-type Natriuretic Peptide (BNP) is a hormone that is made by the pumping chambers of the heart.NCT00330811·Atlanta, Georgia

CompletedA Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1This study will be conducted as a randomized, double-blind, placebo-controlled, multi-center Phase 3 study.NCT03776071·Birmingham, Alabama and 64 others

TerminatedA Study of Atezolizumab (Anti-PD-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and NeckThis study will evaluate the efficacy and safety of atezolizumab compared with placebo as adjuvant therapy after definitive local therapy in patients with high-risk locally…NCT03452137·Duarte, California and 134 others

CompletedEfficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple SclerosisThe primary study objective is to test the superiority of Daclizumab High Yield Process (DAC HYP) compared to interferon β 1a (IFN β-1a) in preventing multiple sclerosis (MS)…NCT01064401·Gilbert, Arizona and 227 others

CompletedA Study of Ravulizumab (ALXN1210) in Children and Adolescents With Paroxysmal Nocturnal HemoglobinuriaThe purpose of this study was to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety, and efficacy of ravulizumab in pediatric participants with paroxysmal nocturnal…NCT03406507·Atlanta, Georgia and 8 others

CompletedDasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid LeukemiaThe primary purpose of this study is to estimate the major cytogenetic response rates of BMS-354825 and imatinib (800 mg/d) in subjects with chronic phase, Philadelphia chromosome…NCT00103844·Birmingham, Alabama and 130 others

TerminatedA 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)This study will assess the long-term safety and tolerability of 350 to 600 mg/day of PD 0332334 administered in split dose (twice daily) in subjects with Generalized Anxiety…NCT00735267·Birmingham, Alabama and 92 others

CompletedEvaluation of TTP399 in Patients With Type 1 DiabetesThe purpose of this study is to evaluate the safety and efficacy of TTP399 in Type 1 diabetics.NCT03335371·Beverly Hills, California and 14 others

CompletedStudy on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPDHyperglycemia is a common complication of corticosteroid (cortisone) therapy.NCT00605007·Atlanta, Georgia

CompletedA Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerThe purpose of this study is to assess the efficacy and safety of trabectedin+DOXIL as a third-line chemotherapy regimen (treatment) in patients with platinum-sensitive…NCT01846611·Birmingham, Alabama and 137 others

TerminatedExtension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderThe primary objective of this study is to evaluate the safety and tolerability of long term (6 months) armodafinil treatment as adjunctive therapy to mood-stabilizing medications…NCT01121536·Birmingham, Alabama and 157 others

CompletedStudy of Micafungin in Patients With Invasive Candidiasis or CandidemiaThe purpose of the study is to determine the safety and effectiveness of two dose levels of micafungin versus caspofungin in the treatment of proven invasive candidiasis or…NCT00105144·Birmingham, Alabama and 166 others

PreviousPage 151 of 651Next

in Atlanta

Heart Diseasein Atlanta